Immunoexpression of FRAP is associated with poor survival in non-small cell lung cancer

被引：0
|
作者：
Sanati, S
Castro, CY
Jones, DV
Xie, J
Haque, AK
机构：
[1] Univ Texas, Med Branch, Galveston, TX 77550 USA
[2] Methodist Hosp, Houston, TX 77030 USA
来源：
MODERN PATHOLOGY | 2005年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1471
引用
下载
收藏
页码：317A / 317A
页数：1
相关论文
共 50 条
  • [21] Overexpression of PTP4A1 is associated with poor overall survival in non-small cell lung cancer
    Wang, Tao
    Shi, Xiaoyi
    Wang, Zhichao
    Liu, Xinyang
    Zhang, Guoliang
    Zhu, Qikun
    Mi, Lili
    Wang, Rui
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (07): : 3583 - 3590
  • [22] Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancer
    Saintigny, Pierre
    Besse, Benjamin
    Callard, Patrice
    Vergnaud, Anne-Claire
    Czernichow, Sebastien
    Colombat, Magali
    Girard, Philippe
    Validire, Pierre
    Breau, Jean-Luc
    Bernaudin, Jean-Francois
    Soria, Jean-Charles
    CLINICAL CANCER RESEARCH, 2007, 13 (16) : 4825 - 4831
  • [23] Postdiagnosis BMI Change Is Associated with Non-Small Cell Lung Cancer Survival
    Yuan, Qianyu
    Du, Mulong
    Loehrer, Elizabeth
    Johnson, Bruce E.
    Gainor, Justin F.
    Lanuti, Michael
    Li, Yi
    Christiani, David C.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (01) : 262 - 268
  • [24] Survival benefits associated with surgery for advanced non-small cell lung cancer
    David, Elizabeth A.
    Andersen, Stina W.
    Beckett, Laurel A.
    Melnikow, Joy
    Clark, James M.
    Brown, Lisa M.
    Cooke, David T.
    Kelly, Karen
    Canter, Robert J.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 157 (04): : 1620 - 1628
  • [25] Survival Prognostication in Non-small Cell Lung Cancer
    Zell, Jason A.
    Ou, Sai-Hong Ignatius
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (07) : 785 - 786
  • [26] Stromal markers of activated tumor associated fibroblasts predict poor survival and are associated with necrosis in non-small cell lung cancer
    Alcaraz, Jordi
    Lluis Carrasco, Josep
    Millares, Laura
    Luis, Iuliana-Cristiana
    Fernandez-Porras, Francisco J.
    Martinez-Romero, Anabel
    Diaz-Valdivia, Natalia
    Sanchez De Cos, Julio
    Rami-Porta, Ramon
    Seijo, Luis
    Ramirez, Josep
    Jose Pajares, Maria
    Reguart, Noemi
    Barreiro, Esther
    Monso, Eduard
    LUNG CANCER, 2019, 135 : 151 - 160
  • [27] Stromal Markers of Activated Tumor Associated Fibroblasts Predict Poor Survival and Are Associated with Necrosis in Non-Small Cell Lung Cancer
    Alcaraz, J.
    Carrasco, J. L.
    Laura, M.
    Martinez-Romero, A.
    Sanchez De Cos, J.
    Rami-Porta, R.
    Seijo, L. M.
    Ramirez, J.
    Reguart, N.
    Barreiro, E.
    Monso, E.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S312 - S312
  • [28] Stromal markers of activated tumor associated fibroblasts predict poor survival and are associated with necrosis in non-small cell lung cancer
    Alcaraz, Jordi
    Carrasco, Josep-Lluis
    Millares, Laura
    Benchea, Iuliana-Cristiana
    Fernandez, Francisco-Javier
    Martinez, Anabel
    Jose Pajares, Maria
    Sanchez de Cos, Julio
    Rami-Porta, Ramon
    Seijo, Luis
    Ramirez, Josep
    Reguart, Noemi
    Barreiro, Esther
    Monso, Eduard
    CANCER RESEARCH, 2019, 79 (13)
  • [29] Expression of TrkB and BDNF is associated with poor prognosis in non-small cell lung cancer
    Okamura, Kyoko
    Harada, Taishi
    Wang, Shuo
    Ijichi, Kayo
    Furuyama, Kazuto
    Koga, Takaomi
    Okamoto, Tatsuro
    Takayama, Koichi
    Yano, Tokujiro
    Nakanishi, Yoichi
    LUNG CANCER, 2012, 78 (01) : 100 - 106
  • [30] EXPRESSION OF TRKB AND BDNF IS ASSOCIATED WITH POOR PROGNOSIS IN NON-SMALL CELL LUNG CANCER
    Okamura, Kyoko
    Harada, Taishi
    Wang, Shuo
    Furuyama, Kazuto
    Ijichi, Kayo
    Koga, Takaomi
    Okamoto, Tatsuro
    Takayama, Koichi
    Yano, Tokujiro
    Nakanishi, Yoichi
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S471 - S471
12345